Skip to main content

Effect of recombinant tissue plasminogen activator on clot lysis and ventricular dilatation in the treatment of severe intraventricular haemorrhage

Summary

Twelve patients with severe intraventricular haemorrhage (IVH) underwent intraventricular thrombolysis with recombinant tissue plasminogen activator (rtPA). External ventricular drainage was performed in all patients within 24 hours of haemorrhage. Fibrinolytic therapy was started within 24 hours from the onset of symptoms in ten cases, and in two further cases after 48 hours and 5 days, respectively. Two to 5 mg of rtPA were injected via the ventricular catheter into one or both lateral ventricles. The injection was repeated at intervals ranging from 6 to 24 hours until CT scans demonstrated a substantial reduction of intraventricular blood. The total rtPA doses per patient ranged from 3 to 31 mg.

CT scans showed a marked reduction of intraventricular blood and normalization of ventricular size within 24 to 48 hours from the beginning of the flbrinolytic therapy. Rapid reduction of elevated intracranial pressure by continuous diversion of cerebrospinal fluid could be achieved in all patients, because the ventricular catheters never became obstructed by clotted blood during the fibrinolytic therapy. During the period of treatment, the level of consciousness, as classified according to the Glasgow Coma Scale, improved from a mean value of 7 to 12. One fatal case of meningitis most probably due to the ventriculostomy was the only complication related to the treatment.

This method of treatment might improve the prognosis in patients in whom a large intraventricular haematoma volume, ventricular dilatation, and impaired cerebrospinal fluid circulation are major determinants for the outcome.

This is a preview of subscription content, access via your institution.

References

  1. de Weerd AW (1979) The prognosis of intraventricular haemorrhage. J Neurol 222: 45–51

    Google Scholar 

  2. Findlay JM, Weir BKA, Gordon P, Grace M, Baughman R (1989) Safety and efficacy of intrathecal thrombolytic therapy in a primate model of cerebral vasospasm. Neurosurgery 24: 491–498

    Google Scholar 

  3. Findlay JM, Weir BKA, Kanamaru K, Grace M, Baughman R (1990) The effect of timing of intrathecal fibrinolytic therapy on cerebral vasospasm in a primate model of subarachnoid haemorrhage. Neurosurgery 26: 201–206

    Google Scholar 

  4. Findlay JM, Weir BKA, Kassell NF, Disney LB, Grace MGA (1991) Intracisternal recombinant tissue plasminogen activator after aneurysmal subarachnoid haemorrhage. J Neurosurg 75: 181–188

    Google Scholar 

  5. Findlay JM, Weir BKA, Stollery DE (1991) Lysis of intraventricular haematoma with tissue plasminogen activator. J Neurosurg 74: 803–807

    Google Scholar 

  6. Graeb DA, Robertson WD, Lapointe JS, Nugent RA, Harrison PB (1982) Computed tomographic diagnosis of intraventricular haemorrhage. Radiology 143: 91–96

    Google Scholar 

  7. LeRoux PD, Haglund MM, Newell DW, Grady MS, Winn HR (1992) Intraventricular haemorrhage in blunt head trauma: an analysis of 43 cases. Neurosurgery 31: 678–685

    Google Scholar 

  8. Little JR, Blomquist GA Jr, Ethier R (1977) Intraventricular haemorrhage in adults. Surg Neurol 8: 143–149

    Google Scholar 

  9. Mohr G, Ferguson G, Khan M, Malloy D, Watts R, Benoit B, Weir B (1983) Intraventricular haemorrhage from ruptured aneurysm. J Neurosurg 58: 482–487

    Google Scholar 

  10. Öhman J, Servo A, Heiskanen O (1991) Effect of intrathecal fibrinolytic therapy on clot lysis and vasospasm in patients with aneurysmal subarachnoid haemorrhage. J Neurosurg 75: 197–201

    Google Scholar 

  11. Pia HW (1972) The surgical treatment of intracerebral and intraventricular haematomas. Acta Neurochir (Wien) 27: 149–164

    Google Scholar 

  12. Ruscalleda J, Peiró A (1986) Prognostic factors in intraparenchymatous haematoma with ventricular haemorrhage. Neuroradiology 28: 34–37

    Google Scholar 

  13. Seifert V, Eisert WG, Stolke D, Goetz C (1989) Efficacy of single intracisternal bolus injection of recombinant tissue plasminogen activator to prevent delayed cerebral vasospasm after experimental subarachnoid haemorrhage. Neurosurgery 25: 590–598

    Google Scholar 

  14. Stolke D, Seifert V (1992) Single intracisternal bolus of recombinant tissue plasminogen activator in patients with aneurysmal subarachnoid haemorrhage: preliminary assessment of efficacy and safety in an open clinical study. Neurosurgery 30: 877–881

    Google Scholar 

  15. Teasdale G, Jennet B (1974) Assessment of coma and impaired consciousness: a practical scale. Lancet 2: 81–84

    Google Scholar 

  16. Todo T, Usui M, Takakura K (1991) Treatment of severe intra-ventricular haemorrhage by intraventricular infusion of urokinase. J Neurosurg 74: 81–86

    Google Scholar 

  17. Zabramski JM, Spetzler RF, Lee KS, Papadopoulos SM, Bovill E, Zimmermann RS, Bederson JB (1991) Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid haemorrhage. J Neurosurg 75: 189–196

    Google Scholar 

Download references

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Mayfrank, L., Lippitz, B., Groth, M. et al. Effect of recombinant tissue plasminogen activator on clot lysis and ventricular dilatation in the treatment of severe intraventricular haemorrhage. Acta neurochir 122, 32–38 (1993). https://doi.org/10.1007/BF01446983

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01446983

Keywords

  • Intraventricular haemorrhage
  • tissue plasminogen activator
  • fibrinolytic therapy
  • ventricular drainage
  • hydrocephalus